Shabbir A, Yumn L, Khan E. Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy. Global Cardiol [Internet]. 2024 Nov. 5 [cited 2024 Nov. 19];2(3). Available from: https://www.globalcardiology.info/site/article/view/48